Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Mitsubishi Chemical Group Corporation (4188.T)
Tokyo, JP
Established in 2005 and headquartered in Tokyo, Japan, Mitsubishi Chemical Group Corporation operates globally, offering a vast array of products and specialized services. The company's diverse portfolio includes advanced performance materials, fundamental chemicals, industrial gases, and a comprehensive suite of healthcare solutions. Its performance materials segment features specialty chemicals, functional food ingredients, inorganic compounds, electronic and electrical components, molded and processed goods, various films and sheets, synthetic and carbon fibers, alongside a wide range of equipment and systems. This division also provides materials for industrial applications, construction, civil engineering, and water-related projects, as well as consumer goods for leisure, sports, and everyday use. Within the healthcare sector, the corporation delivers pharmaceuticals, drug formulation substances, and innovative drug discovery solutions. It also supplies diagnostic reagents, medical instruments, and offers extensive support services spanning medical care, nursing assistance, general health support, and clinical examinations. Furthermore, Mitsubishi Chemical Group provides essential industrial materials like basic chemicals, carbon products, synthetic resins, and a variety of industrial gases. Complementing its product offerings, the company's service capabilities are robust, covering engineering, information technology, analysis, inspection, packaging, logistics, surveying, consulting, transportation, and warehousing.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.80% | +9.75% | +4.74% | -8.69% | +17.27% | +9.10% | +34.38% | +26.75% | +19.76% | +80.68% | +31.35% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 8 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals: +4.0%-16.0% Q1'26: -10.1% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-72.7% Q1'26: -575.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+8.1% ★ Q1'26: +11.2% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+6.9% Q1'26: +7.8% (vs Q1'25)
-
ROIC Chemicals: +3.4%+4.1% ★ Q1'26: +7.1% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-3.7% ★ Q1'26: -3.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×3.58× Q1'26: 3.28× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 10 Rev. Ana. 7 EPS Ana. |
Mar 2027 12 Rev. Ana. 12 EPS Ana. |
Mar 2028 11 Rev. Ana. 11 EPS Ana. |
Mar 2029 2 Rev. Ana. 2 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.66T
est: 3.65T (+0.1%)
|
3.82T
est: 3.88T (-1.5%)
|
3.38T
est: 3.35T (+0.7%)
|
3.72T
est: 3.75T (-0.6%)
|
3.92T
est: 3.98T (-1.4%)
|
3.58T
est: 3.61T (-0.8%)
|
3.26T
est: 3.22T (+1.3%)
|
3.98T
est: 3.95T (+0.6%)
|
4.63T
est: 4.65T (-0.4%)
|
4.39T
est: 4.46T (-1.5%)
|
4.41T
est: 4.40T (+0.3%)
|
3.69T
3.63T – 3.74T
-16.1% YoY
|
3.89T
3.71T – 4.14T
+5.5% YoY
|
3.93T
3.80T – 4.12T
+1.0% YoY
|
3.96T
3.80T – 4.18T
+0.6% YoY
|
4.18T
4.01T – 4.41T
+5.6% YoY
|
| EBITDA |
355.62B
est: 408.49B (-12.9%)
|
418.40B
est: 434.14B (-3.6%)
|
449.31B
est: 374.95B (+19.8%)
|
540.05B
est: 419.01B (+28.9%)
|
507.52B
est: 445.32B (+14.0%)
|
387.65B
est: 403.82B (-4.0%)
|
299.56B
est: 359.92B (-16.8%)
|
564.03B
est: 442.42B (+27.5%)
|
468.97B
est: 520.73B (-9.9%)
|
561.06B
est: 531.03B (+5.7%)
|
481.62B
est: 523.94B (-8.1%)
|
439.76B
432.42B – 446.36B
-16.1% YoY
|
463.76B
442.30B – 493.34B
+5.5% YoY
|
468.57B
453.41B – 491.25B
+1.0% YoY
|
471.55B
453.03B – 497.97B
+0.6% YoY
|
497.83B
478.28B – 525.73B
+5.6% YoY
|
| EBIT |
183.22B
est: 173.61B (+5.5%)
|
217.64B
est: 184.51B (+18.0%)
|
275.27B
est: 159.35B (+72.7%)
|
361.16B
est: 178.08B (+102.8%)
|
308.19B
est: 189.26B (+62.8%)
|
147.83B
est: 171.62B (-13.9%)
|
55.77B
est: 152.96B (-63.5%)
|
312.56B
est: 188.03B (+66.2%)
|
199.35B
est: 221.31B (-9.9%)
|
285.63B
est: 305.56B (-6.5%)
|
205.68B
est: 301.47B (-31.8%)
|
253.04B
248.81B – 256.84B
-16.1% YoY
|
266.85B
254.50B – 283.87B
+5.5% YoY
|
269.62B
260.89B – 282.67B
+1.0% YoY
|
271.33B
260.67B – 286.53B
+0.6% YoY
|
286.45B
275.20B – 302.50B
+5.6% YoY
|
| Net Income |
60.86B
est: 48.37B (+25.8%)
|
46.44B
est: 33.53B (+38.5%)
|
156.26B
est: 151.70B (+3.0%)
|
211.79B
est: 202.15B (+4.8%)
|
169.53B
est: 186.36B (-9.0%)
|
54.08B
est: 71.58B (-24.5%)
|
-7.56B
est: -39.24B (+80.7%)
|
177.16B
est: 182.80B (-3.1%)
|
96.07B
est: 114.44B (-16.1%)
|
119.60B
est: 116.71B (+2.5%)
|
45.02B
est: 66.76B (-32.6%)
|
45.19B
26.02B – 81.99B
-32.3% YoY
|
91.86B
59.73B – 137.50B
+103.3% YoY
|
115.94B
91.00B – 160.31B
+26.2% YoY
|
139.60B
134.09B – 158.15B
+20.4% YoY
|
167.11B
158.58B – 179.29B
+19.7% YoY
|
| SGA |
532.18B
est: 706.37B (-24.7%)
|
625.12B
est: 750.73B (-16.7%)
|
714.72B
est: 648.37B (+10.2%)
|
764.32B
est: 724.56B (+5.5%)
|
800.84B
est: 770.07B (+4.0%)
|
800.57B
est: 698.31B (+14.6%)
|
752.69B
est: 622.39B (+20.9%)
|
854.46B
est: 765.05B (+11.7%)
|
922.65B
est: 900.48B (+2.5%)
|
932.35B
est: 960.21B (-2.9%)
|
970.02B
est: 947.38B (+2.4%)
|
795.18B
781.90B – 807.11B
-16.1% YoY
|
838.58B
799.77B – 892.05B
+5.5% YoY
|
847.27B
819.85B – 888.28B
+1.0% YoY
|
852.65B
819.16B – 900.42B
+0.6% YoY
|
900.18B
864.83B – 950.62B
+5.6% YoY
|
| EPS |
41.40
est: 33.98 (+21.8%)
|
31.71
est: 23.55 (+34.6%)
|
104.97
est: 106.57 (-1.5%)
|
147.14
est: 142.02 (+3.6%)
|
119.22
est: 130.92 (-8.9%)
|
26.19
est: 50.29 (-47.9%)
|
-5.32
est: -27.57 (+80.7%)
|
124.68
est: 128.42 (-2.9%)
|
67.57
est: 80.40 (-16.0%)
|
84.07
est: 82.04 (+2.5%)
|
31.64
est: 46.40 (-31.8%)
|
40.24
18.28 – 57.60
-13.3% YoY
|
69.82
41.96 – 96.59
+73.5% YoY
|
89.99
63.93 – 112.62
+28.9% YoY
|
102.65
94.20 – 111.10
+14.1% YoY
|
117.40
111.41 – 125.95
+14.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-15 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Manabu Chikumoto | President, Chief Executive Officer, Representative Corporate Executive Officer & Director | 94M | male |
| Ken Araki | Executive Officer & Chief Transformation Officer | — | — |
| Kenichi Takahashi | General Manager of the Accounting Department & Corporate Finance Division | — | — |
| Koji Fujita | Corporate Secretary Department & Commercial Law Group Chief | — | — |
| Masahiko Tanaka | Executive Officer & Chief Human Resource Officer | — | — |
| Minoru Kida | Vice President & Chief Financial Officer | — | male |
| Noriyuki Mita | Executive Officer & Chief Sustainability Officer | — | — |
| Osamu Shimizu | General Manager of Public Relations & Investor Relations Office | — | male |
| Isao Yano | Representative Corporate Executive Officer & Chief Compliance Officer | — | — |
| Tappei Shimizu | Director of Investor Relations Office | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4188.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
